LJUBLJANA, Nov 21 (Reuters) - Slovenian pharmaceutical producer Krka KRKG.LJ made a group net profit of 171.9 million euros ($190.3 million) in the first nine months of 2019 versus 120.8 million in the same period of 2018, the company said in a statement on Thursday.
It added full year profit will reach about 200 million euros compared to 172 million expected earlier and forecast a profit of 210 million euros next year.
($1 = 0.9032 euros)
(Reporting By Marja Novak; Editing by Toby Chopra)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.